Monte Rosa Therapeutics, Inc. (GLUE) — Net Income
| Fiscal Year | Net Income | Change YoY |
|---|---|---|
| 2025 | -$38.63M | +46.9% |
| 2024 | -$72.70M | +46.3% |
| 2023 | -$135.35M | -24.7% |
| 2022 | -$108.50M | -46.7% |
| 2021 | -$73.96M | -106.1% |
| 2020 | -$35.88M | — |
| Fiscal Year | Net Income | Change YoY |
|---|---|---|
| 2025 | -$38.63M | +46.9% |
| 2024 | -$72.70M | +46.3% |
| 2023 | -$135.35M | -24.7% |
| 2022 | -$108.50M | -46.7% |
| 2021 | -$73.96M | -106.1% |
| 2020 | -$35.88M | — |